MedTrace Logo

Ease of Use Study of the FemPulse System

NCT06885099 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2026-02-06

No results posted yet for this study

Summary

The objective of the study is to demonstrate that the FemPulse System can be used as indicated

Conditions

  • Overactive Bladder (OAB)

Interventions

DEVICE

FemPulse System

Subjects to receive the FemPulse System consisting of a non-implanted, vaginal electrical stimulation device (Ring) and other patient accessories.

Sponsors & Collaborators

  • FemPulse Corporation

    lead INDUSTRY

Principal Investigators

  • Roshini Jain · FemPulse Corporation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-11
Primary Completion
2025-07-31
Completion
2025-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06885099 on ClinicalTrials.gov